Literature DB >> 10851084

Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway.

K Honda1, H Mihara, Y Kato, A Yamaguchi, H Tanaka, H Yasuda, K Furukawa, T Urano.   

Abstract

Human Aurora2 was originally identified by its close homology to yeast IPL1 and fly aurora, which are key regulators of chromosome segregation and a family of serine/threonine kinases. Here we demonstrate that the Aurora2 protein is degraded rapidly after G2/M phase release in mammalian cells. Aurora2 protein has a rapid turnover rate with a half-life of approximately 2 h. In eukaryotic cells, the ubiquitin-proteasome pathway is the major mechanism for the targeted degradation of unstable proteins. The treatment of mammalian cells with proteasome inhibitors blocks Aurora2 degradation. Furthermore, Aurora2 is polyubiquitinated in vivo and in vitro using anaphase-promoting complex (APC). These results demonstrate that Aurora2 protein is turned over through the APC-ubiquitin-proteasome pathway. Oncogene (2000) 19, 2812 - 2819

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851084     DOI: 10.1038/sj.onc.1203609

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

1.  APC/Fizzy-Related targets Aurora-A kinase for proteolysis.

Authors:  Anna Castro; Yannick Arlot-Bonnemains; Suzanne Vigneron; Jean-Claude Labbé; Claude Prigent; Thierry Lorca
Journal:  EMBO Rep       Date:  2002-04-18       Impact factor: 8.807

2.  Global control of histone modification by the anaphase-promoting complex.

Authors:  Vijay Ramaswamy; Jessica S Williams; Karen M Robinson; Richelle L Sopko; Michael C Schultz
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  The D-Box-activating domain (DAD) is a new proteolysis signal that stimulates the silent D-Box sequence of Aurora-A.

Authors:  Anna Castro; Suzanne Vigneron; Cyril Bernis; Jean-Claude Labbé; Claude Prigent; Thierry Lorca
Journal:  EMBO Rep       Date:  2002-11-21       Impact factor: 8.807

4.  Sequence characterization and promoter identification of porcine APC10 gene.

Authors:  W B He; Z W Wang; Y Li; Z L Tang; S L Yang; Y L Mu; K M Peng; K Li
Journal:  Mol Biol Rep       Date:  2010-03-16       Impact factor: 2.316

5.  Nonparametric Bayesian evaluation of differential protein quantification.

Authors:  Oliver Serang; A Ertugrul Cansizoglu; Lukas Käll; Hanno Steen; Judith A Steen
Journal:  J Proteome Res       Date:  2013-09-11       Impact factor: 4.466

6.  Functional interaction of Aurora-A and PP2A during mitosis.

Authors:  Virginie Horn; Jacques Thélu; Alphonse Garcia; Corinne Albigès-Rizo; Marc R Block; Jean Viallet
Journal:  Mol Biol Cell       Date:  2007-01-17       Impact factor: 4.138

7.  Mitotic regulation of the stability of microtubule plus-end tracking protein EB3 by ubiquitin ligase SIAH-1 and Aurora mitotic kinases.

Authors:  Reiko Ban; Hideki Matsuzaki; Tomohiro Akashi; Gyosuke Sakashita; Hisaaki Taniguchi; Sam-Yong Park; Hirofumi Tanaka; Koichi Furukawa; Takeshi Urano
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

8.  Aurora-A kinase is essential for bipolar spindle formation and early development.

Authors:  Dale O Cowley; Jaime A Rivera-Pérez; Mark Schliekelman; Yizhou Joseph He; Trudy G Oliver; Lucy Lu; Ryan O'Quinn; E D Salmon; Terry Magnuson; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

9.  Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit.

Authors:  Laurie E Littlepage; Joan V Ruderman
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

10.  Binding partner switching on microtubules and aurora-B in the mitosis to cytokinesis transition.

Authors:  Nurhan Ozlü; Flavio Monigatti; Bernhard Y Renard; Christine M Field; Hanno Steen; Timothy J Mitchison; Judith J Steen
Journal:  Mol Cell Proteomics       Date:  2009-09-28       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.